Biomarker Qualification Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biomarker qualification program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biomarker Qualification Program Today - Breaking & Trending Today

Four pancreatic injury safety biomarkers identified and evaluated by PSTC, finds study

Critical Path Institute (C-Path) today announced that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) in the U.S. Food and Drug Administration (FDA) issued a Biomarker Letter of Support (LOS) for four pancreatic injury safety biomarkers identified and evaluated by C-Path's Predictive Safety Testing Consortium's (PSTC) Pancreatic Injury Working Group (PIWG). ....

Warren Glaab , Danielle Ellis , Nicholas King , Michael Ringenberg , Nonclinical Drug Safety At Merck Co Inc , Biomarker Qualification Program , Pancreatic Injury Working Group , Critical Path Institute , Predictive Safety Testing Consortium , Drug Administration , Path Institute , Drug Evaluation , Biomarker Letter , Executive Director , Systems Toxicology , Nonclinical Drug Safety , Chair Warren Glaab , Senior Scientific Director ,

Worldwide Biomarkers Industry to 2025 - by Product Type, Technology Type, Therapeutic Area and End-user


Share this article
Share this article
ResearchAndMarkets.com s offering.
This new report, Biomarkers: Technologies and Global Markets, provides a comprehensive analysis of the biomarkers market in a global context, including market forecasts and sales through 2025. The report analyzes the market, segmenting it into various product offerings (i.e., instruments, consumables [reagents, kits and panels], services and software). Segmentation also provides analysis by popular technology type (genomics, proteomics and metabolomics, imaging and bioinformatics).
This study surveys the biomarker market by therapeutic area (cancer, cardiovascular and metabolic diseases, infectious diseases, neurodegenerative diseases, autoimmune diseases and others. End-users include academic institutes, pharma and biotechnology companies, clinical research organizations, hospitals and diagnostics. Geographic regions include North America, Europe and Emerging markets. Emerging markets include ....

United States , New Zealand , Leica Biosystems , Laura Wood , Koninklijke Philips , Abcam Plc , Abbott Laboratories Ltd , Lantheus Medical Imaging Inc , Beckman Coulter Life Sciences , Biomarker Qualification Program , Pacific Biosciences Inc , Technology Type , Fujifilm Visual Sonics Inc , Becton Dickinson Co , Office Hours Call , Canon Medical Corp , Drug Administration , Metabolon Inc , Roche Molecular Systems Inc , Bio Techne Corp , Drug Development , Association For Molecular Pathology , Shimadzu Corp , Oxford Nanopore Technologies Ltd , Clinical Research Organizations Cros , Waters Corp ,